GUARD — Guard Therapeutics International AB (publ) Cashflow Statement
0.000.00%
- SEK295.45m
- SEK241.26m
Annual cashflow statement for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -40.3 | -81.9 | -115 | -115 | -99.9 |
Depreciation | |||||
Non-Cash Items | — | 0.52 | 0.67 | 2.83 | 2.82 |
Other Non-Cash Items | |||||
Changes in Working Capital | 2.16 | 3.79 | 12.1 | -3.81 | 2.33 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -38 | -77.6 | -102 | -116 | -94.8 |
Other Investing Cash Flow Items | 0.118 | 0 | 0 | 0 | 0 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.118 | 0 | 0 | 0 | 0 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 74 | 176 | 113 | -0.779 | 62.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 36.2 | 98.6 | 12.4 | -117 | -29.6 |